<![CDATA[ Your latest Press Releases ]]> 10<![CDATA[ DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21597 <![CDATA[ Cytomedix to Host Fourth Quarter and Fiscal Year 2012 Financial Results Conference Call on Tuesday, March 19, 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21639 <![CDATA[ BrainStorm Cell Therapeutics Presents Breakthrough Phase I/II ALS Clinical Data at the American Academy of Neurology Annual Meeting ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21666 <![CDATA[ Nanosphere Obtains CE Mark for Gram-Negative Blood Culture Test ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21671 <![CDATA[ DelMar Pharma Named to Rocket Builders' 2013"Ready to Rocket" List ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21673 <![CDATA[ Cytomedix to Present at the Canaccord Genuity Musculoskeletal Conference ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21730 <![CDATA[ Cytomedix Announces Centers for Medicare & Medicaid Services (CMS) Issuance Of Reimbursement Coding for Autologous PRP in Chronic Non-Healing Wounds ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21746 <![CDATA[ Phase II ALS Clinical Trial With BrainStorm Cell Therapeutics' NurOwn™ to Be Expanded to a Third Premiere U.S. Clinical Site ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21747 <![CDATA[ Cytomedix Reports 2012 Fourth Quarter and Full Year Financial Results ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21774 <![CDATA[ Results of NurOwn™ Clinical Trial Suggest Efficacy in ALS Patients ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21831 <![CDATA[ Rockwell Medical Submits Calcitriol Manufacturing Data to FDA for Approval ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22005 <![CDATA[ DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22017 <![CDATA[ Cytomedix Announces Appointment of Steven A. Shallcross as Chief Financial Officer ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22023 <![CDATA[ La Jolla Pharmaceutical Company Announces Fourth-Quarter and Full-Year 2012 Financial Results and Highlights Recent Corporate Progress ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22030 <![CDATA[ LifeSci Advisors Initiates Coverage of Adocia ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22073 <![CDATA[ La Jolla Pharmaceutical Announces Start of Common Stock Quotation on OTCBB ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22079 <![CDATA[ LifeSci Advisors Initiates Coverage of Celsus Therapeutics ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22136 <![CDATA[ BrainStorm Partners With Dana-Farber for NurOwn™ Production in Phase II ALS Clinical Trial ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22143 <![CDATA[ Cytomedix, Inc. to Present at Regen Med Investor Day 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22186 <![CDATA[ DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22194 <![CDATA[ BrainStorm to Present at Several Scientific and Investment Conferences ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22199 <![CDATA[ Celsus Therapeutics Announces Notification of Patents Granted ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22258 <![CDATA[ La Jolla Pharmaceutical Company Receives Orphan Designation From FDA for LJPC-6417 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22329 <![CDATA[ Nanosphere Welcomes Ken Bahk, Ph.D. as Chief Strategy Officer and Announces Other Management Changes ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22446 <![CDATA[ Cytomedix to Present at the 12th Annual Needham Healthcare Conference ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22457 <![CDATA[ Celsus Therapeutics Strengthens Board of Directors With Addition of Pharma/Biotech Industry Veteran Fredric Price ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22471 <![CDATA[ Nanosphere to Release First Quarter 2013 Results and Hold Investor Conference Call on Wednesday, May 8, 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22510 <![CDATA[ LifeSci Advisors Initiates Coverage of Brainstorm Cell Therapeutics ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22525 <![CDATA[ Celsus Therapeutics Strengthens Board of Directors With Addition of Dermatology Industry Veteran Robert F. Doman ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22528 <![CDATA[ Cytomedix AutoloGel™ Registry to Be Featured at the Symposium on Advanced Wound Care (SAWC-SPRING) on May 5, 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22586 <![CDATA[ Rockwell Medical Schedules 1st Quarter 2013 Investor Conference Call ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22598 <![CDATA[ Rockwell Medical to Present ESA-Sparing PRIME Study Data at 50th ERA-EDTA Congress, Istanbul 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22607 <![CDATA[ Cytomedix to Host First Quarter 2013 Financial Results Conference Call on Friday, May 10, 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22609 <![CDATA[ La Jolla Pharmaceutical Company Announces Completion of Phase 1 Portion of GCS-100 Clinical Trial in Chronic Kidney Disease ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22617 <![CDATA[ LIFESCI ADVISORS INITIATES COVERAGE OF LIPOCINE INC ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22651 <![CDATA[ Nanosphere Announces Record First Quarter Revenues and Strengthens Balance Sheet with $27 Million Debt and Equity Financing ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22699 <![CDATA[ Celsus Therapeutics Announces Positive Phase II Interim Results for MRX-6 in the Treatment of Contact Dermatitis ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22701 <![CDATA[ Cytomedix Reports First Quarter 2013 Financial Results ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22741 <![CDATA[ Nanosphere Announces Distribution and Collaboration Agreement With Hitachi High-Technologies Corporation ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22797 <![CDATA[ La Jolla Pharmaceutical Company Announces First-Quarter 2013 Financial Results and Highlights Recent Corporate Progress ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22814 <![CDATA[ La Jolla Pharmaceutical Company Presents Corporate Update at the MoneyShow ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22845 <![CDATA[ LifeSci Advisors Initiates Coverage of Prothena Corporation ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22859 <![CDATA[ Nanosphere to Present at UBS Global Healthcare Conference ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22862 <![CDATA[ New Validation and Clinical Outcome Data From Several Studies on Nanosphere's Gram-Positive and Gram-Negative Blood Culture Tests to Be Presented at ASM 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22922 <![CDATA[ DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22923 <![CDATA[ Rockwell Medical Presents PRIME Study Results at the 50th ERA-EDTA Meeting in Istanbul, Turkey ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22931 <![CDATA[ Rockwell Medical Announces the Exercise of Over-Allotment Option ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22939 <![CDATA[ Cytomedix to Present at the World Stem Cells & Regenerative Medicine Congress 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22945 <![CDATA[ Rockwell Medical Closes $40.3 Million Public Offering of Common Stock ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22984 <![CDATA[ BrainStorm Provides Update on Clinical Trial and Scientific Conference Activities ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=23006